A PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE HEADACHES AND A COSOLVENT METHOD OF PREPARATION THEREOF

The present disclosure provides a pharmaceutical composition for the treatment of migraines, the pharmaceutical composition comprises dihydroergotamine or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier without the need for caffeine as prservative. The present di...

Full description

Saved in:
Bibliographic Details
Main Author AL-GHANANEEM, Abeer
Format Patent
LanguageEnglish
French
Published 13.01.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides a pharmaceutical composition for the treatment of migraines, the pharmaceutical composition comprises dihydroergotamine or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier without the need for caffeine as prservative. The present disclosure further provides a method for producing the pharmaceutical composition. La présente invention concerne une composition pharmaceutique pour le traitement des migraines, la composition pharmaceutique comprenant de la dihydroergotamine ou ses sels pharmaceutiquement acceptables, et un support pharmaceutiquement acceptable sans avoir recours à la caféine comme agent de conservation. La présente invention concerne également un procédé de production de la composition pharmaceutique.
Bibliography:Application Number: WO2020JO50005